SLXN Stock Analysis: Buy, Sell, or Hold?
SLXN - Silexion Therapeutics Corp Ordinary Shares
$1.77
-0.03 (-1.67%)
▼
5d:
-15.31%
30d:
-5.85%
90d:
-46.59%
HOLD
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Mar 17, 2026
Get Alerted When SLXN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SLXN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SLXN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SLXN is currently trading at $1.77, which is considered oversold relative to its 30-day fair value range of $1.90 to $2.23.
Technical Outlook: Technically, SLXN is in a strong downtrend. The price is currently testing key support at $1.76. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SLXN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $9.00 (+400.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SLXN is in a strong downtrend. The price is currently testing key support at $1.76. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SLXN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $9.00 (+400.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.90 -
$2.23
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 400.0% below Wall St target ($9.00)
- CAUTION: 5-day price weakness (-15.3%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.90 -
$2.23
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.76
Resistance Level
$2.30
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.41
Wall Street Target
$9.00
(+400.0%)
Last updated: February 03, 2026 2:23 PM ET
Data refreshes hourly during market hours. Next update: 3:23 PM
Data refreshes hourly during market hours. Next update: 3:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLXN showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 57 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 60 HOLD |
|
ALLO
Allogene Therapeutics Inc |
STRONG BUY
14 analysts |
$7 | 62 BUY |
